Loading clinical trials...
Loading clinical trials...
Prophylactic Application of Donor-derived Central Memory T Lymphocytes (TCM) After Allogeneic HSCT to Prevent Infectious Complications
Conditions
Interventions
TCM allogeneic humane central memory T cells, cryopreserved
Locations
1
Germany
University Hospital Wuerzburg - Department of Medicine II
Würzburg, Germany
Start Date
April 1, 2016
Primary Completion Date
May 1, 2021
Completion Date
May 1, 2021
Last Updated
July 13, 2022
NCT06303193
NCT06847867
NCT06439199
NCT07216443
NCT06656494
NCT05588154
Lead Sponsor
Wuerzburg University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions